These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31131878)

  • 1. Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target.
    Orouji E; Federico A; Larribère L; Novak D; Lipka DB; Assenov Y; Sachindra S; Hüser L; Granados K; Gebhardt C; Plass C; Umansky V; Utikal J
    Int J Cancer; 2019 Dec; 145(12):3462-3477. PubMed ID: 31131878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking histone methyltransferase SETDB1 inhibits tumorigenesis and enhances cetuximab sensitivity in colorectal cancer.
    Hou Z; Sun L; Xu F; Hu F; Lan J; Song D; Feng Y; Wang J; Luo X; Hu J; Wang G
    Cancer Lett; 2020 Sep; 487():63-73. PubMed ID: 32473242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
    Wong CM; Wei L; Law CT; Ho DW; Tsang FH; Au SL; Sze KM; Lee JM; Wong CC; Ng IO
    Hepatology; 2016 Feb; 63(2):474-87. PubMed ID: 26481868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone Methyltransferase SETDB1: A Common Denominator of Tumorigenesis with Therapeutic Potential.
    Strepkos D; Markouli M; Klonou A; Papavassiliou AG; Piperi C
    Cancer Res; 2021 Feb; 81(3):525-534. PubMed ID: 33115801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset.
    Ceol CJ; Houvras Y; Jane-Valbuena J; Bilodeau S; Orlando DA; Battisti V; Fritsch L; Lin WM; Hollmann TJ; Ferré F; Bourque C; Burke CJ; Turner L; Uong A; Johnson LA; Beroukhim R; Mermel CH; Loda M; Ait-Si-Ali S; Garraway LA; Young RA; Zon LI
    Nature; 2011 Mar; 471(7339):513-7. PubMed ID: 21430779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SETDB1, an H3K9-specific methyltransferase: An attractive epigenetic target to combat cancer.
    Prashanth S; Radha Maniswami R; Rajajeyabalachandran G; Jegatheesan SK
    Drug Discov Today; 2024 May; 29(5):103982. PubMed ID: 38614159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming.
    Torrano J; Al Emran A; Hammerlindl H; Schaider H
    Clin Epigenetics; 2019 Mar; 11(1):43. PubMed ID: 30850015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis.
    Rodriguez-Paredes M; Martinez de Paz A; Simó-Riudalbas L; Sayols S; Moutinho C; Moran S; Villanueva A; Vázquez-Cedeira M; Lazo PA; Carneiro F; Moura CS; Vieira J; Teixeira MR; Esteller M
    Oncogene; 2014 May; 33(21):2807-13. PubMed ID: 23770855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent co-alteration of HDGF and SETDB1 on chromosome 1q drives cutaneous melanoma progression and poor prognosis.
    Fazio M; van Rooijen E; Mito JK; Modhurima R; Weiskopf E; Yang S; Zon LI
    Pigment Cell Melanoma Res; 2021 May; 34(3):641-647. PubMed ID: 33064882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitination of Lysine 867 of the Human SETDB1 Protein Upregulates Its Histone H3 Lysine 9 (H3K9) Methyltransferase Activity.
    Ishimoto K; Kawamata N; Uchihara Y; Okubo M; Fujimoto R; Gotoh E; Kakinouchi K; Mizohata E; Hino N; Okada Y; Mochizuki Y; Tanaka T; Hamakubo T; Sakai J; Kodama T; Inoue T; Tachibana K; Doi T
    PLoS One; 2016; 11(10):e0165766. PubMed ID: 27798683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-frequency p16(INK) (4A) promoter methylation is associated with histone methyltransferase SETDB1 expression in sporadic cutaneous melanoma.
    Kostaki M; Manona AD; Stavraka I; Korkolopoulou P; Levidou G; Trigka EA; Christofidou E; Champsas G; Stratigos AJ; Katsambas A; Papadopoulos O; Piperi C; Papavassiliou AG
    Exp Dermatol; 2014 May; 23(5):332-8. PubMed ID: 24673285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SETDB1: Progress and prospects in cancer treatment potential and inhibitor research.
    Ma T; Xu F; Hou Y; Shu Y; Zhao Z; Zhang Y; Bai L; Feng L; Zhong L
    Bioorg Chem; 2024 Apr; 145():107219. PubMed ID: 38377821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SETDB1 plays an essential role in maintenance of gonocyte survival in pigs.
    Liu T; Zhang P; Li T; Chen X; Zhu Z; Lyu Y; Li X; Tian X; Zeng W
    Reproduction; 2017 Jul; 154(1):23-34. PubMed ID: 28420800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone methyltransferase SETDB1 maintains survival of mouse spermatogonial stem/progenitor cells via PTEN/AKT/FOXO1 pathway.
    Liu T; Chen X; Li T; Li X; Lyu Y; Fan X; Zhang P; Zeng W
    Biochim Biophys Acta Gene Regul Mech; 2017 Oct; 1860(10):1094-1102. PubMed ID: 28890329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic regulation in human melanoma: past and future.
    Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
    Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal Setdb1 Is Required for Meiotic Progression and Preimplantation Development in Mouse.
    Kim J; Zhao H; Dan J; Kim S; Hardikar S; Hollowell D; Lin K; Lu Y; Takata Y; Shen J; Chen T
    PLoS Genet; 2016 Apr; 12(4):e1005970. PubMed ID: 27070551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemistry for histone h3 lysine 9 methyltransferase and demethylase proteins in human melanomas.
    Miura S; Maesawa C; Shibazaki M; Yasuhira S; Kasai S; Tsunoda K; Maeda F; Takahashi K; Akasaka T; Masuda T
    Am J Dermatopathol; 2014 Mar; 36(3):211-6. PubMed ID: 24658378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitination-dependent and -independent repression of target genes by SETDB1 reveal a context-dependent role for its methyltransferase activity during adipogenesis.
    Zhang J; Matsumura Y; Kano Y; Yoshida A; Kawamura T; Hirakawa H; Inagaki T; Tanaka T; Kimura H; Yanagi S; Fukami K; Doi T; Osborne TF; Kodama T; Aburatani H; Sakai J
    Genes Cells; 2021 Jul; 26(7):513-529. PubMed ID: 33971063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Updating of Biological Functions of Methyltransferase SETDB1 and Its Relevance in Lung Cancer and Mesothelioma.
    Yuan L; Sun B; Xu L; Chen L; Ou W
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SETDB1 promotes gastric carcinogenesis and metastasis via upregulation of CCND1 and MMP9 expression.
    Shang W; Wang Y; Liang X; Li T; Shao W; Liu F; Cui X; Wang Y; Lv L; Chai L; Qu L; Zheng L; Jia J
    J Pathol; 2021 Feb; 253(2):148-159. PubMed ID: 33044755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.